Biogened S.A. (WSE:BGD)
24.30
+0.39 (1.64%)
At close: Sep 10, 2025
Biogened Market Cap
Biogened has a market cap or net worth of 58.46 million as of September 12, 2025. Its market cap has decreased by -21.71% in one year.
Market Cap
58.46M
Enterprise Value
82.02M
Revenue
112.75M
Ranking
n/a
PE Ratio
10.02
Stock Price
24.30
Market Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 58.46M, an increase of 27.73%. That is a compound annual growth rate of 1.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 60.92M | 7.83% |
Dec 30, 2024 | 56.50M | 27.78% |
Dec 29, 2023 | 44.21M | 41.73% |
Dec 29, 2022 | 31.20M | 47.67% |
Dec 30, 2021 | 21.12M | 1.18% |
Dec 30, 2020 | 20.88M | 21.43% |
Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Orlen | 95.71B |
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna | 90.23B |
Powszechny Zaklad Ubezpieczen | 53.30B |
Santander Bank Polska | 51.32B |
Bank Polska Kasa Opieki | 47.47B |
Dino Polska | 46.08B |
ING Bank Slaski | 40.27B |
mBank | 38.59B |